- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT04153292
ENCIRCLE 시험 (ENCIRCLE)
경중격 액세스를 통한 SAPIEN M3 시스템 경피적 승모판 교체
This study will establish the safety and effectiveness of the SAPIEN M3 System in subjects with symptomatic, at least 3+ mitral regurgitation (MR) for whom commercially available surgical or transcatheter treatment options are deemed unsuitable.
Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.
연구 개요
상세 설명
This is a prospective single-arm, multicenter study.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Leiden, 네덜란드, 2333 ZA
- Leiden University Medical Center
-
Rotterdam, 네덜란드, 3015 CE
- Rotterdam Erasmus MC
-
-
-
-
Alabama
-
Huntsville, Alabama, 미국, 35801
- Heart Center Hospital
-
-
Arizona
-
Phoenix, Arizona, 미국, 85006
- Banner University Medical Center
-
Phoenix, Arizona, 미국, 85013
- Saint Josephs Hospital Medical Center Dignity Health
-
-
California
-
La Jolla, California, 미국, 92037
- Scripps Health
-
Los Angeles, California, 미국, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, 미국, 90017
- Good Samaritan Hospital
-
Los Angeles, California, 미국, 90071
- Kaiser Sunset LA
-
San Francisco, California, 미국, 94109
- California Pacific Medical Center
-
-
Colorado
-
Loveland, Colorado, 미국, 80538
- UC Health Northern Colorado (Medical Center of the Rockies)
-
-
Florida
-
Gainesville, Florida, 미국, 32605
- Cardiac & Vascular Institute Foundation
-
Jacksonville, Florida, 미국, 32204
- Ascension St. Vincent's Hospital
-
Naples, Florida, 미국, 34102
- Naples Community Hospital
-
Sarasota, Florida, 미국, 34239
- Sarasota Memorial Hospital
-
-
Georgia
-
Atlanta, Georgia, 미국, 30308
- Emory University
-
Atlanta, Georgia, 미국, 30309
- Piedmont Healthcare
-
-
Illinois
-
Glenview, Illinois, 미국, 60026
- Northshore University Health System
-
-
Kansas
-
Kansas City, Kansas, 미국, 66160
- University of Kansas
-
Wichita, Kansas, 미국, 67226
- Cardiovascular Research Institute of Kansas (CRIOK)
-
-
Louisiana
-
Baton Rouge, Louisiana, 미국, 70808
- Our Lady of the Lake Regional Medical Center
-
-
Maryland
-
Baltimore, Maryland, 미국, 21218
- Medstar Union Memorial Hospital
-
-
Massachusetts
-
Boston, Massachusetts, 미국, 02114
- Massachusetts General Hospital
-
-
Michigan
-
Detroit, Michigan, 미국, 48202
- Henry Ford
-
-
Minnesota
-
Rochester, Minnesota, 미국, 55905
- Mayo Clinic
-
Saint Cloud, Minnesota, 미국, 56303
- CentraCare
-
-
Missouri
-
Kansas City, Missouri, 미국, 64111
- Saint Luke's Kansas City
-
-
New Hampshire
-
Lebanon, New Hampshire, 미국, 03756
- Dartmouth-Hitchcock Medical Center
-
-
New Jersey
-
New Brunswick, New Jersey, 미국, 08901
- Robert Wood Johnson University Hospital
-
-
New York
-
Buffalo, New York, 미국, 14203
- University of Buffalo
-
New York, New York, 미국, 10007
- Weill Cornell Medicine
-
-
North Carolina
-
Charlotte, North Carolina, 미국, 28204
- Novant Health and Vascular Institute
-
-
Ohio
-
Cincinnati, Ohio, 미국, 45219
- The Christ Hospital
-
Cleveland, Ohio, 미국, 44122
- Cleveland Clinic Foundation
-
Columbus, Ohio, 미국, 43123
- Mount Carmel East Hospital
-
-
Oklahoma
-
Oklahoma City, Oklahoma, 미국, 73120
- Oklahoma Heart Hospital
-
Tulsa, Oklahoma, 미국, 74104
- Oklahoma Heart Institute
-
-
Pennsylvania
-
Mechanicsburg, Pennsylvania, 미국, 17050
- UPMC Heart and Vascular Institute
-
-
Tennessee
-
Nashville, Tennessee, 미국, 37205
- Saint Thomas Health
-
-
Texas
-
Austin, Texas, 미국, 78705
- Austin Heart
-
Houston, Texas, 미국, 77030
- UT Memorial Hermann
-
Houston, Texas, 미국, 77004
- HCA Houston Healthcare Medical (SCRI)
-
-
Utah
-
Murray, Utah, 미국, 84107
- Intermountain Medical Center
-
-
Virginia
-
Norfolk, Virginia, 미국, 23507
- Sentara Norfolk
-
Roanoke, Virginia, 미국, 24014
- Carilion Roanoke Memorial Hospital
-
-
Washington
-
Seattle, Washington, 미국, 98195
- University of Washington Seattle
-
-
-
-
-
London, 영국, EC1A 7BE
- Saint Bartholomew's Medical Center
-
London, 영국, SE1 7EH
- Saint Thomas Hospital
-
-
-
-
-
Petah Tikva, 이스라엘, 4941492
- Rabin Medical Center
-
-
-
-
-
Toronto, 캐나다, M5B 1W8
- St. Michael's
-
Vancouver, 캐나다, V6E 1M7
- St. Pauls
-
-
Quebec
-
Québec, Quebec, 캐나다, G1V 0A6
- Laval University
-
-
-
-
-
Camperdown, 호주, NSW2050
- Royal Prince Alfred Hospital
-
-
Queensland
-
Chermside, Queensland, 호주, 4032
- The Prince Charles Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- 18 years of age or older
- MR ≥ 3+
- NYHA functional class ≥ II
- Per the Heart Team, commercially available surgical or transcatheter treatment options are deemed unsuitable due to clinical, anatomic or technical considerations.
- Subject's heart failure management has been optimized based on subject characteristics and applicable guidelines, and stable for at least 30 days prior to enrollment.
- The subject or subject's legal representative has been informed of the nature of the study, agrees to its provisions and has provided written informed consent.
Exclusion Criteria:
- Mitral/cardiac anatomy that would preclude appropriate delivery and deployment of the SAPIEN M3 dock or valve
- Inappropriate anatomy for femoral introduction and delivery of the SAPIEN M3 dock and valve
- Presence of any device that will contact or interfere with the SAPIEN M3 System during delivery or after implantation
- Left ventricular ejection fraction <25%
- Severe right ventricular dysfunction
- Need for aortic, tricuspid or pulmonic valve intervention within the next 12 months
- History of heart transplant
- Cardiac imaging evidence of intracardiac mass, thrombus or vegetation
- Active bacterial endocarditis within 180 days of the procedure
- Hemodynamic instability requiring inotropic or mechanical support within 30 days of the procedure
- Myocardial infarction within 30 days of the procedure
- Clinically significant untreated coronary artery disease requiring revascularization
- Any percutaneous cardiovascular intervention, cardiovascular surgery, or carotid surgery within 30 days of the procedure
- Stroke or transient ischemic attack within 90 days of the procedure
- Irreversible, severe pulmonary hypertension
- Chronic obstructive pulmonary disease requiring home oxygen therapy or chronic outpatient oral steroid use
- Renal insufficiency or receiving renal replacement therapy
- Liver disease
- Planned surgery within the next 12 months
- Inability to tolerate or a medical condition precluding treatment with antithrombotic therapy, including heparin administration during the procedure
- Active infection requiring current antibiotic therapy
- Active SARS-CoV-2 infection (Coronavirus-19 [COVID-19]) or previously diagnosed with COVID-19 with sequelae that could confound endpoint assessments
- Leukopenia, anemia, thrombocytopenia, history of bleeding diathesis or coagulopathy or hypercoagulable states
- Refusal of blood products
- Female who is pregnant or lactating
- Estimated life expectancy <12 months due to non-cardiac conditions
- Participating in another investigational drug or device study that has not reached its primary endpoint
- Subject considered to be part of a vulnerable population
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위화되지 않음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: TMVR - Main Cohort
Subjects for whom commercially available surgical or transcatheter treatment options are deemed unsuitable will have transcatheter mitral valve replacement (TMVR). |
During the procedure a SAPIEN M3 dock and a SAPIEN M3 valve will be implanted via transseptal approach. |
|
실험적: TMVR - Failed TEER Registry
Subjects who have had an attempted but failed transcatheter edge-to-edge repair (TEER) procedure will have TMVR. |
During the procedure a SAPIEN M3 dock and a SAPIEN M3 valve will be implanted via transseptal approach. |
|
실험적: TMVR - MAC Registry
Subjects with mitral annular calcification (MAC) will have TMVR. |
During the procedure a SAPIEN M3 dock and a SAPIEN M3 valve will be implanted via transseptal approach. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Non-hierarchical composite of death and heart failure rehospitalization
기간: 1 year
|
Number of subjects with death and/or heart failure rehospitalization |
1 year
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Improvement in NYHA functional class compared to baseline
기간: 1 year
|
New York Heart Association (NYHA) functional classification of heart failure is based on how much a patient is limited during physical activity. The rating ranges from I-IV. I = no limitations of physical activity; II = slight limitations of physical activity, ordinary physical activity results in fatigue, palpitation, shortness of breath; III = marked limitations of physical activity, less than ordinary activity causes fatigue, palpitation, or shortness of breath; IV = unable to carry on any physical activity without discomfort, symptoms of heart failure at rest. |
1 year
|
|
Improvement in KCCQ Overall Score compared to baseline
기간: 1 year
|
The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a 23-item, self-administered instrument that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. An overall summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains. Scores are transformed to a range of 0-100, in which higher scores reflect better health status. |
1 year
|
|
Improvement in MR compared to baseline
기간: 1 year
|
Number of subjects with improved MR compared to baseline |
1 year
|
|
Decrease in LVEDVi compared to baseline
기간: 1 year
|
Number of subjects with decreased left ventricular end-diastolic volume index (LVEDVi) compared to baseline |
1 year
|
공동 작업자 및 조사자
수사관
- 수석 연구원: John Webb, MD, St. Paul's Hospital
- 수석 연구원: Mayra Guerrero, MD, Mayo Clinic
- 수석 연구원: David Daniels, MD, California Pacific Medical Center
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .